BeStock  
Stocks › Biotechnology › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2271Biotechnology
$21.73 −$0.98 (-4.32%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $22.00 +1.24%
Open$22.11
Prev close$22.71
Day range$21.63 – $23.05
Volume1.74M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership136.6%+8.57 pts vs. prior quarter
Institutions holding307+11 vs. prior quarter
Insider trades (recent)25 buys / 22 sellsNet buying
Short interest28.61% of floatDays to cover 9.7 · as of 30 Oct 2026
Short-sale volume share21.4%5-day average of daily volume

Short-sale volume as % of daily volume

11%17%23%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$12.21M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$12.2MSuper+$56.5KBig−$1.7MMid+$745.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 44.5% of shares outstanding.

Largest holders

  • FMR14.92%
  • RTW Investments, LP8.20%
  • BlackRock7.76%
  • Farallon Capital Management, L.L.C.7.24%
  • Boxer Capital Management, LLC6.42%
  • The Goldman Sachs Group, Inc.5.69%
  • TCG Crossover Management, LLC5.36%
  • State Street Global Advisors4.32%

By investor type

  • Mutual Fund58.82%
  • Hedge Fund50.96%
  • VC/PE Fund18.75%
  • Public Company7.21%
  • Individual/Insider1.06%
  • Private Company0.30%
  • Insurance Company0.26%
  • Government Pension Fund0.23%

Reported short interest has risen from 25.61% to 28.61% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +12,953,285 14.9%
State Street Global Advisors Mutual Fund 2026/Q3 +1,335,595 4.3%
BlackRock Mutual Fund 2026/Q3 +704,625 7.8%
Artal Group S.A. VC/PE Fund 2026/Q3 +604,717 4.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +560,265 3.8%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +5,271,521 3.9%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +4,770,352 5.7%
BlackRock Mutual Fund 2026/Q3 +3,690,399 7.4%
Farallon Capital Management, L.L.C. Hedge Fund 2026/Q3 +3,179,589 7.2%
Janus Henderson Group plc Mutual Fund 2026/Q3 +2,661,380 3.0%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +2,568,847 2.0%
FMR Mutual Fund 2026/Q3 +2,427,419 7.3%
Seven Fleet Capital Management LP Hedge Fund 2026/Q3 +2,425,484 1.9%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +2,347,844 3.8%
Commodore Capital LP Hedge Fund 2026/Q3 +2,250,000 1.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Nov 2026 Jessica Newcomb Automatic Disposition -7,031 $22.98 8,424
1 Nov 2026 Adam Crystal President of Research & Development Derivative Exercise and Sale -5,000 $22.99 17,230
30 Sep 2026 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $25.32 17,230
21 Sep 2026 Jessica Newcomb Automatic Disposition -8,200 $25.17 15,455
31 Aug 2026 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $22.37 17,230
2 Aug 2026 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $27.35 17,230
30 Jun 2026 Adam Crystal President of Research & Development Derivative Exercise and Sale -27,000 $30.25 17,230
18 Jun 2026 Robert Azelby Independent Chairperson Other Acquisition +5,740 – 5,740
18 Jun 2026 Robert Azelby Independent Chairperson Other Derivative Acquisition +35,910 $27.97 35,910
16 Jun 2026 Nextech Invest Ltd. Intent to Sell (Form 144) -3,766,081 $30.10 –
10 Jun 2026 Daniella Beckman Former Chief Financial Officer Intent to Sell (Form 144) -1,791,726 $28.76 –
9 Jun 2026 Daniella Beckman Former Chief Financial Officer Intent to Sell (Form 144) -4,446 $30.00 –
4 Jun 2026 Mace Rothenberg Independent Director Other Acquisition +4,000 – 4,000
4 Jun 2026 Mace Rothenberg Independent Director Other Derivative Acquisition +25,000 $20.22 25,000
4 Jun 2026 Lesley Calhoun Independent Director Other Acquisition +4,000 – 4,000
4 Jun 2026 Lesley Calhoun Independent Director Other Derivative Acquisition +25,000 $20.22 25,000
4 Jun 2026 John Ketchum Independent Director Other Acquisition +4,000 – 7,333
4 Jun 2026 John Ketchum Independent Director Other Derivative Acquisition +25,000 $20.22 25,000
4 Jun 2026 Sung Lee Lead Independent Director Other Acquisition +570 – 22,870
4 Jun 2026 Sung Lee Lead Independent Director Other Derivative Acquisition +3,570 $20.22 3,570

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 48,239,154 28.6% 9.7
15 Oct 2026 44,777,592 26.6% 11.2
30 Sep 2026 44,500,110 26.4% 12.5
15 Sep 2026 41,872,812 24.8% 18.8
31 Aug 2026 42,627,550 25.3% 19.7
14 Aug 2026 43,186,169 25.6% 20.9

Discussion

No comments yet — be the first to weigh in on TNGX.

Sign in to join the discussion.

Scroll to Top